Skip to main navigation Skip to search Skip to main content

Integrated protocol for exitron and exitron-derived neoantigen identification using human RNA-seq data with ScanExitron and ScanNeo

Research output: Contribution to journalArticlepeer-review

Abstract

Exitron splicing (EIS) events in cancers can disrupt functional protein domains to cause cancer driver effects. EIS has been recognized as a new source of tumor neoantigens. Here, we describe an integrated protocol for EIS and EIS-derived neoantigen identification using RNA-seq data. The protocol constitutes a step-by-step guide from data collection to neoantigen prediction. For complete details on the use and execution of this protocol, please refer to Wang et al. (2021).

Original languageEnglish (US)
Article number100788
JournalSTAR Protocols
Volume2
Issue number3
DOIs
StatePublished - Sep 17 2021

Bibliographical note

Publisher Copyright:
© 2021 The Author(s)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Bioinformatics
  • Cancer
  • Genetics
  • Genomics
  • Immunology
  • RNAseq

Fingerprint

Dive into the research topics of 'Integrated protocol for exitron and exitron-derived neoantigen identification using human RNA-seq data with ScanExitron and ScanNeo'. Together they form a unique fingerprint.

Cite this